Individuals with diabetes taking semaglutide may be at a 4x greater risk for developing NAION
We review your metabolic markers, body fat distribution, health history, and weight loss goals to determine whether AOD-9604 is the right fit
Each order includes a Certificate of Analysis (COA), detailing purity and identity confirmed through third-party lab verification
If you are taking a related licensed medicine such as semaglutide (Ozempic or Wegovy) or tirzepatide (Mounjaro), which act on overlapping receptor pathways and are experiencing nausea, it is entirely appropriate to discuss this with your GP or prescriber
they are biological forces that shape metabolism, symptom burden, and potentially responses to cornerstone diabetes treatments
Hot flushessudden feelings of warmth, typically affecting the face, neck, and chestare not listed as an official adverse effect of Ozempic (semaglutide) in UK regulatory documentation